Literature DB >> 27917870

High-Frequency Stimulation of the Subthalamic Nucleus Blocks Compulsive-Like Re-Escalation of Heroin Taking in Rats.

Carrie L Wade1, Marsida Kallupi1, Daniel O Hernandez1, Emmanuel Breysse1,2, Giordano de Guglielmo1, Elena Crawford1, George F Koob1, Paul Schweitzer1, Christelle Baunez2, Olivier George1.   

Abstract

Opioid addiction, including addiction to heroin, has markedly increased in the past decade. The cost and pervasiveness of heroin addiction, including resistance to recovery from addiction, provide a compelling basis for developing novel therapeutic strategies. Deep brain stimulation may represent a viable alternative strategy for the treatment of intractable heroin addiction, particularly in individuals who are resistant to traditional therapies. Here we provide preclinical evidence of the therapeutic potential of high-frequency stimulation of the subthalamic nucleus (STN HFS) for heroin addiction. STN HFS prevented the re-escalation of heroin intake after abstinence in rats with extended access to heroin, an animal model of compulsive heroin taking. STN HFS inhibited key brain regions, including the substantia nigra, entopeduncular nucleus, and nucleus accumbens shell measured using brain mapping analyses of immediate-early gene expression and produced a robust silencing of STN neurons as measured using whole-cell recording ex vivo. These results warrant further investigation to examine the therapeutic effects that STN HFS may have on relapse in humans with heroin addiction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27917870      PMCID: PMC5520777          DOI: 10.1038/npp.2016.270

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  43 in total

1.  High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons.

Authors:  C Beurrier; B Bioulac; J Audin; C Hammond
Journal:  J Neurophysiol       Date:  2001-04       Impact factor: 2.714

2.  High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task.

Authors:  Yassine Darbaky; Claude Forni; Marianne Amalric; Christelle Baunez
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

3.  Years of potential life lost among heroin addicts 33 years after treatment.

Authors:  Breda Smyth; Valerie Hoffman; Jing Fan; Yih-Ing Hser
Journal:  Prev Med       Date:  2007-02-08       Impact factor: 4.018

4.  Deep brain stimulation of the nucleus accumbens shell attenuates cocaine reinstatement through local and antidromic activation.

Authors:  Fair M Vassoler; Samantha L White; Thomas J Hopkins; Leonardo A Guercio; Julie Espallergues; Olivier Berton; Heath D Schmidt; R Christopher Pierce
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

5.  Dynamic vaccine blocks relapse to compulsive intake of heroin.

Authors:  Joel E Schlosburg; Leandro F Vendruscolo; Paul T Bremer; Jonathan W Lockner; Carrie L Wade; Ashlee A K Nunes; G Neil Stowe; Scott Edwards; Kim D Janda; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

6.  Compulsions, Parkinson's disease, and stimulation.

Authors:  Luc Mallet; Valérie Mesnage; Jean-Luc Houeto; Antoine Pelissolo; Jérôme Yelnik; Cécile Behar; Marcella Gargiulo; Marie-Laure Welter; Anne-Marie Bonnet; Bernard Pillon; Philippe Cornu; Didier Dormont; Bernard Pidoux; Jean-François Allilaire; Yves Agid
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

7.  Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction.

Authors:  J Kuhn; M Möller; J F Treppmann; C Bartsch; D Lenartz; T O J Gruendler; M Maarouf; A Brosig; U B Barnikol; J Klosterkötter; V Sturm
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

8.  High-frequency electrical stimulation of the subthalamic nucleus excites target structures in a model using c-fos immunohistochemistry.

Authors:  S Shehab; C D'souza; M Ljubisavljevic; P Redgrave
Journal:  Neuroscience       Date:  2014-04-19       Impact factor: 3.590

9.  Stimulation of subthalamic nucleus inhibits emotional activation of fusiform gyrus.

Authors:  Jacob Geday; Karen Ostergaard; Albert Gjedde
Journal:  Neuroimage       Date:  2006-09-07       Impact factor: 6.556

10.  Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study.

Authors:  Florence Le Jeune; Marc Vérin; Karim N'Diaye; Dominique Drapier; Emmanuelle Leray; Sophie Tezenas Du Montcel; Nicolas Baup; Antoine Pelissolo; Mircea Polosan; Luc Mallet; Jérome Yelnik; Bertrand Devaux; Denys Fontaine; Isabelle Chereau; Aurélie Bourguignon; Julie Peron; Paul Sauleau; Sylvie Raoul; Etienne Garin; Marie-Odile Krebs; Nematollah Jaafari; Bruno Millet
Journal:  Biol Psychiatry       Date:  2010-10-16       Impact factor: 13.382

View more
  14 in total

1.  Subthalamic low-frequency oscillations predict vulnerability to cocaine addiction.

Authors:  Mickael Degoulet; Alix Tiran-Cappello; Etienne Combrisson; Christelle Baunez; Yann Pelloux
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

2.  Subthalamic nucleus high frequency stimulation prevents and reverses escalated cocaine use.

Authors:  Yann Pelloux; Mickaël Degoulet; Alix Tiran-Cappello; Candie Cohen; Sylvie Lardeux; Olivier George; George F Koob; Serge H Ahmed; Christelle Baunez
Journal:  Mol Psychiatry       Date:  2018-06-07       Impact factor: 15.992

3.  Targeting the subthalamic nucleus in a preclinical model of alcohol use disorder.

Authors:  Yann Pelloux; Christelle Baunez
Journal:  Psychopharmacology (Berl)       Date:  2017-04-11       Impact factor: 4.530

Review 4.  Deep brain stimulation for the treatment of drug addiction.

Authors:  Tony R Wang; Shayan Moosa; Robert F Dallapiazza; W Jeffrey Elias; Wendy J Lynch
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

5.  Compulsive-Like Sufentanil Vapor Self-Administration in Rats.

Authors:  Janaina C M Vendruscolo; Brendan J Tunstall; Stephanie A Carmack; Brooke E Schmeichel; Emily G Lowery-Gionta; Maury Cole; Olivier George; Sophia A Vandewater; Michael A Taffe; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2017-08-16       Impact factor: 7.853

Review 6.  At the heart of the interoception network: Influence of the parasubthalamic nucleus on autonomic functions and motivated behaviors.

Authors:  Tanvi Shah; Jeffery L Dunning; Candice Contet
Journal:  Neuropharmacology       Date:  2021-11-29       Impact factor: 5.250

7.  Deep brain stimulation of the nucleus accumbens shell attenuates cocaine withdrawal but increases cocaine self-administration, cocaine-induced locomotor activity, and GluR1/GluA1 in the central nucleus of the amygdala in male cocaine-dependent rats.

Authors:  Marsida Kallupi; Jenni Kononoff; Philippe A Melas; Johanna S Qvist; Giordano de Guglielmo; Eric R Kandel; Olivier George
Journal:  Brain Stimul       Date:  2021-11-03       Impact factor: 8.955

8.  Chemogenetic modulation reveals distinct roles of the subthalamic nucleus and its afferents in the regulation of locomotor sensitization to amphetamine in rats.

Authors:  K G Nakata; E Yin; E Sutlief; Susan M Ferguson
Journal:  Psychopharmacology (Berl)       Date:  2021-09-22       Impact factor: 4.530

9.  Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.

Authors:  Adam Kimbrough; Jenni Kononoff; Sierra Simpson; Marsida Kallupi; Sharona Sedighim; Kenia Palomino; Dana Conlisk; Jeremiah D Momper; Giordano de Guglielmo; Olivier George
Journal:  Psychopharmacology (Berl)       Date:  2020-02-29       Impact factor: 4.530

10.  Neurons in the Monkey's Subthalamic Nucleus Differentially Encode Motivation and Effort.

Authors:  Simon Nougaret; Christelle Baunez; Sabrina Ravel
Journal:  J Neurosci       Date:  2022-02-01       Impact factor: 6.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.